Man Group
APTO

Man Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Man Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-776
Closed -$472K – 2437
2021
Q4 		$472K Buy
776
+196
+34% +$184K ﹤0.01% 1553
2021
Q3 		$569K Buy
580
+252
+77% +$315K ﹤0.01% 1501
2021
Q2 		$489K Sell
328
-103
-24% -$224K ﹤0.01% 1566
2021
Q1 		$1.16M Buy
431
+31
+8% +$61.5K 0.01% 1253
2020
Q4 		$789K Buy
400
+189
+90% +$444K ﹤0.01% 1465
2020
Q3 		$569K Buy
+211
New +$526K ﹤0.01% 1525
2020
Q1 		– Sell
-488
Closed -$1.25M – 1961
2019
Q4 		$1.25M Sell
488
-3,088
-86% -$4.02M ﹤0.01% 1455
2019
Q3 		$3.36M Buy
3,576
+284
+9% +$323K 0.01% 1052
2019
Q2 		$3.87M Buy
+3,292
New +$3.03M 0.01% 1053

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Man Group's APTO Position: Q1 2022 in Review

Man Group sold out of Aptose Biosciences, Inc. (APTO) in Q1 2022, closing a stake of 776 shares — an estimated $472K sold.

Man Group first reported a position in APTO in Q2 2019 and held it in 9 quarters. The position peaked at $3.87M in Q2 2019. 52 funds tracked by Wall St. Rank hold APTO as of Q1 2022.

  • Man Group reported no remaining Aptose Biosciences, Inc. position as of Q1 2022 after selling out during the quarter.
  • Man Group sold 776 Aptose Biosciences, Inc. shares in Q1 2022, an estimated $472K.
  • Man Group first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 9 quarters.
  • Man Group's Aptose Biosciences, Inc. position peaked at $3.87M in Q2 2019.
  • 52 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2022.

Based on Man Group's 13F filing for Q1 2022, filed 16 May 2022.